Liam Ratcliffe's Net Worth
Estimate Recalculated Dec 3, 2025 08:04PM EST
Who is Liam Ratcliffe
Liam Ratcliffe has an estimated net worth of $1.52 Million. This is based on reported shares across multiple companies, which include Relypsa Inc, Eliem Therapeutics, Inc., Deciphera Pharmaceuticals, Inc., iRhythm Technologies, Inc., Unum Therapeutics Inc., ARVINAS INC., Oxford Immunotec Global PLC, CONCERT PHARMACEUTICALS, INC., Edge Therapeutics, Inc., Iterum Therapeutics plc, Passage BIO, Inc., Durata Therapeutics, Inc., Aptinyx Inc., Versartis, Inc., CHIMERIX INC, Disc Medicine, Inc., ARRAY BIOPHARMA INC, and MEI Pharma, Inc..
SEC CIK
Liam Ratcliffe's CIK is 0001547100
Past Insider Trading and Trends
2019 was Liam Ratcliffe's most active year for acquiring shares with 6 total transactions. Liam Ratcliffe's most active month to acquire stocks was the month of May. 2021 was Liam Ratcliffe's most active year for disposing of shares, totalling 8 transactions. Liam Ratcliffe's most active month to dispose stocks was the month of October. 2021 saw Liam Ratcliffe paying a total of $544,531.38 for 62,852 shares, this is the most they've acquired in one year. In 2021 Liam Ratcliffe cashed out on 43,346 shares for a total of $2,275,362.04, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
